I agree that this site is using cookies. You can find further informations here.
X
Masuda, Masayuki
797  results:
Search for persons X
?
1

Factors promoting research activities among Japanese pharma..:

Takigawa, Masaki ; Kondo, Yuki ; Kobayashi, Yutaka...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Uptake of Fluorescein via a pH-Dependent Monocarboxylate Tr..:

Takiguchi, Takaharu ; Sugio, Kazuaki ; Masuda, Masayuki..
Biological and Pharmaceutical Bulletin.  47 (2024)  1 - p. 79-87 , 2024
Link: https://doi.org/10.1248/..
 
?
3

Therapeutic Responses to Efgartigimod for Generalized Myast..:

Suzuki, Shigeaki ; Uzawa, Akiyuki ; Nagane, Yuriko...
Neurology Clinical Practice.  14 (2024)  3 - p. , 2024
Link: https://doi.org/10.1212/..
 
?
4

Real‐world experience with eculizumab and switching to ravu..:

Tokuyasu, Daiki ; Suzuki, Shigeaki ; Uzawa, Akiyuki...
Annals of Clinical and Translational Neurology.  11 (2024)  5 - p. 1338-1346 , 2024
Link: https://doi.org/10.1002/..
 
?
5

Données en vie réelle de l'utilisation d'éculizumab chez de..:

Delain, Jean-Christophe ; Watanabe, Mitsuru ; Takahashi, Masanori...
Revue Neurologique.  180 (2024)  - p. S120 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Elderly Woman With No Autoimmune Disease With Aseptic Menin..:

Takigawa, Masaki ; Tanaka, Hiroyuki ; Kobayashi, Takashi...
Cureus.  , 2024
Link: https://doi.org/10.7759/..
 
?
7

Taste disorders and alopecia in myasthenia gravis:

Uzawa, Akiyuki ; Suzuki, Shigeaki ; Kuwabara, Satoshi...
BMC Neurology.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
8

Long-term safety and efficacy of zilucoplan in patients wit..:

Howard Jr, James F. ; Bresch, Saskia ; Farmakidis, Constantine...
Therapeutic Advances in Neurological Disorders.  17 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
9

Impact of Early Treatment with Intravenous High-Dose Methyl..:

Uzawa, Akiyuki ; Suzuki, Shigeaki ; Kuwabara, Satoshi...
Neurotherapeutics.  20 (2023)  2 - p. 518-523 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Subgroup outcomes from RAISE: A randomized, Phase 3 trial o..:

Weiss, Michael D. ; Bresch, Saskia ; Freimer, Miriam...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
11

Assessing the extent of symptom control provided by ravuliz..:

Kielhorn, Adrian ; Werneburg, Brian ; Hagenacker, Tim...
Journal of the Neurological Sciences.  455 (2023)  - p. 122034 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Efficacy and safety of zilucoplan in Japanese patients with..:

Utsugisawa, Kimiaki ; Deguchi, Kazushi ; Konno, Shingo...
Clinical and Experimental Neuroimmunology.  15 (2023)  1 - p. 45-54 , 2023
Link: https://doi.org/10.1111/..
 
?
13

Clinical features and outcomes of patients with muscle-spec..:

Yasuda, Manato ; Uzawa, Akiyuki ; Kuwabara, Satoshi...
Journal of Neuroimmunology.  385 (2023)  - p. 578241 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Japan MG registry: Chronological surveys over 10 years:

Suzuki, Shigeaki ; Masuda, Masayuki ; Uzawa, Akiyuki...
Clinical and Experimental Neuroimmunology.  14 (2022)  1 - p. 5-12 , 2022
Link: https://doi.org/10.1111/..
 
?
15

Pure red cell aplasia and re‐aggravation of myasthenia grav..:

Yamazaki, Jun ; Ueta, Yuki ; Akiba, Yuki...
Clinical and Experimental Neuroimmunology.  12 (2021)  3 - p. 175-178 , 2021
Link: https://doi.org/10.1111/..
 
1-15